Generate Biomedicines, Inc. Earnings Per Share (Basic)
Generate Biomedicines, Inc. (GENB) reported Earnings Per Share (Basic) of -$0.52 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Generate Biomedicines, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.52.
- Generate Biomedicines, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.07.
- Generate Biomedicines, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.94.
- Generate Biomedicines, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$1.62.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month |
|---|---|---|
| 2026-06-30 | -$0.52 10-Q · filed 2026-08-06 | -$1.41 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$1.07 10-Q · filed 2026-05-07 | |
| 2025-06-30 | -$1.94 10-Q · filed 2026-08-06 | -$3.57 10-Q · filed 2026-08-06 |
| 2025-03-31 | -$1.62 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |